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ABSTRACT: The synthetic biology toolbox lacks extendable and
conformationally controllable yet easy-to-synthesize building blocks
that are long enough to span membranes. To meet this need, an
iterative synthesis of α-aminoisobutyric acid (Aib) oligomers was used to
create a library of homologous rigid-rod 310-helical foldamers, which have
incrementally increasing lengths and functionalizable N- and C-termini.
This library was used to probe the inter-relationship of foldamer length,
self-association strength, and ionophoric ability, which is poorly
understood. Although foldamer self-association in nonpolar chloroform
increased with length, with a ∼14-fold increase in dimerization constant
from Aib6 to Aib11, ionophoric activity in bilayers showed a stronger
length dependence, with the observed rate constant for Aib11 ∼70-fold
greater than that of Aib6. The strongest ionophoric activity was observed
for foldamers with >10 Aib residues, which have end-to-end distances
greater than the hydrophobic width of the bilayers used (∼2.8 nm); X-ray crystallography showed that Aib11 is 2.93 nm long.
These studies suggest that being long enough to span the membrane is more important for good ionophoric activity than strong
self-association in the bilayer. Planar bilayer conductance measurements showed that Aib11 and Aib13, but not Aib7, could form
pores. This pore-forming behavior is strong evidence that Aibm (m ≥ 10) building blocks can span bilayers.
■ INTRODUCTION
Foldamers are synthetic oligomers that can mimic some of the
structural complexity of proteins and peptides without the
constraints imposed by natural biopolymers. Like many
peptides, in solution these oligomers can fold into conforma-
tionally stable structures which have large and structurally well-
deﬁned surfaces that are able to interact with individual
biopolymers or biomolecular assemblies. For example,
foldamers have been used to replicate protein−protein
interactions1 and to form foldamer−DNA complexes for gene
delivery,2 suggesting a role in a number of biomedical
applications.
In recent years there have been a number of reports of
foldamers displaying membrane activity, for example mimicking
cell-penetrating peptides3 and antimicrobial agents,4 with the
latter implying that foldamers could address the growing
problem of antibiotic resistance.5 Like the antimicrobial
peptides (AMPs), these foldamers may produce pores after
spanning the membrane, although membrane disruption is
another mechanism suggested to be behind AMP antibacterial
activity.6 However, for many AMPs and foldamers7 the
mechanisms behind cell toxicity are poorly understood.
Peptide foldamers containing high proportions of α-amino-
isobutyric acid (Aib) have a number of attractive features as
membrane-spanning building blocks, including high hydro-
phobicity and a propensity to adopt rigid-rod 310-helical
secondary structures in a variety of solvents. Moreover,
extended sequences of Aib are found in peptaibols, a class of
naturally occurring AMPs produced by Trichoderma fungi.
These AMPs are mostly between 11 and 21 residues long, often
with a high Aib content, and are typically terminated by an N-
terminal acyl group and a C-terminal 1,2-aminoalcohol
residue.8 Since Aib residues stabilize 310 helices,
9 shown
schematically in Figure 1a, such peptaibols can have 310-helical
and/or α-helical secondary structures.10
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One well-studied peptaibol is alamethicin, which can adopt
membrane-spanning orientations in membranes and produce
ion channels.11,12 The mixed 310- and α-helical conformation of
this 19-residue peptide13 results in suﬃcient length to span the
2.0−2.8 Å hydrophobic section of the phospholipid bilayer at
the center of the cell membrane.13a,14 Alamethicin acts through
a “barrel-stave” mechanism in which multimeric channels are
formed by the self-association of 3−12 helical monomers,
yielding parallel bundles with a central hydrophilic pore.11,12
The number of alamethicin peptides in a bundle is dynamic,
with diﬀerent conductance levels observed for bundles of
diﬀerent molecularity.15 Nonetheless, shorter peptaibols that
cannot span a bilayer, such as the trichogins,16 are also
membrane-active, including 6-residue trichodecinin I17 and 4-
residue peptaibolin,18 showing that the relationship between
peptaibol length and ionophoric activity is unclear.19 A family
of foldamers with incrementally increasing lengths may throw
light on this relationship, with such a study also identifying the
minimum foldamer lengths needed to span diﬀerent
phospholipid bilayers.
There have been a handful of investigations into the
relationship between ionophore length and membrane activity,
with most using conformationally ﬂexible systems. Although
ionophoric activity was not assessed, a small family of
homologous lipopeptaibols structurally related to the trichogins
was assayed for membrane disruption. Release of dye from
vesicles occurred upon addition of 11-, 15-, and 19-residue
peptides, with the 15-mer most active, but not the 7-residue
homologue.20 Sakai and Matile reported that a rigid-rod
tetriphenyl exhibited no membrane activity, but homologous
rigid-rod sexiphenyls (2.6 nm long) and octiphenyls (3.4 nm
long) acted as ionophores; the latter was three times more
active than the former.21 Gokel et al. investigated ﬂexible
channel-forming ionophores, which comprised three 4,13-diaza-
18-crown-6 macrocycles connected by incrementally longer
alkyl chains (−(CH2CH2)n−, n = 4, 5, 6, 7, 8). The rate
constant for sodium ion transport across vesicle membranes
increased 200-fold from n = 4 to n = 6, and then halved for n =
8.22 Interestingly, these compounds had antibiotic activity, with
the n = 6 compound 13 times more eﬀective at killing
ampicillin-resistant E. coli than the n = 4 homologue.23
Although these studies imply that longer compounds should
be more membrane-active than shorter ones and hint that an
optimal length may exist, several questions remain unanswered.
For example, the relationship between length and self-
association strength is poorly understood, which is especially
important for the multimeric barrel-stave channels formed by
oligophenyls or peptaibols. Ionophore ﬂexibility also compli-
cates the analysis of length-dependent behavior, as long, ﬂexible
compounds might still adopt conformations with high
membrane activity. The ideal system for a systematic study
would be based on conformationally deﬁned structures that can
be extended in small increments. Such a study would produce a
nanoscale scaﬀold optimized for spanning a given bilayer and
useable as a potential building block for truly synthetic biology
in a membrane or new generation antibiotics. Furthermore, any
building block will need chemical functionality at both ends
that allows it to be integrated into more complex constructs.
We now describe the synthesis and analysis of a series of 310-
helical foldamers built exclusively from Aib residues, ranging
from 5 to 13 residues in length (Figure 1a). A ﬂexible strategy
was developed for the synthesis of the “Aibm” oligomers that
gave incrementally extendable mimics of the pore-forming
peptaibols, structures with chemical functionality at both
termini and without complicating side chain functionality.
The ionophoric activity of each of these compounds was
assessed and used to probe how the activity of helical peptides
in bilayer membranes depended on both self-association
strength and chain length (Figure 1b), with the adoption of
membrane-spanning conformations conﬁrmed using planar
bilayer conductance assays.
■ RESULTS AND DISCUSSION
Design and Synthesis of Aib Foldamers 1−9. A
homologous series of foldamers was synthesized that varied
only in their length (Scheme 1). As Aib is an achiral residue,
these oligomers exist as an equal ratio of M and P 310-helical
conformers that interconvert on a submillisecond time scale at
room temperature.24 The shortest Aib foldamer 1 was designed
to have suﬃcient length to give one turn of a 310 helix (>4
residues) in solution,25 and this core unit was extended by an
iterative synthetic strategy (Scheme 1). By this method, a family
of foldamers was created with lengths predicted to be up to and
beyond the thickness of a typical bilayer. Groups were
incorporated at the termini (azido at the N-terminus and 2-
(trimethylsilyl)ethyl, CH2CH2SiMe3, at the C-terminus) which
not only facilitated this iterative synthetic procedure but also
minimized end-to-end intermolecular interactions.25 These
terminal groups will permit the synthesis of functionalized
derivatives, either after deprotection or through “click”
chemistry. In a 310-helical conformation with a typical rise-
per-residue of 1.94 Å, the lengths of compounds 1−9 were
anticipated to lie between 1.8 and 3.4 nm.26 These foldamers
are all relatively hydrophobic, facilitating partitioning into
phospholipid bilayers from the buﬀer.27
Solid State Structures. Crystal structures were obtained
for N3Aib7OCH2CH2TMS 3, N3Aib8OCH2CH2TMS 4, and
N3Aib11OCH2CH2TMS 7, which conﬁrmed the adoption of
310-helical conformations stabilized by intramolecular hydrogen
bonds (Figure 2a−c).
The extended conformations adopted by 3 and 7 gave head-
to-tail distances (CH3 to N3) of 2.25 and 2.93 nm. These values
Figure 1. (a) 310-Helical Aib foldamers 1−9. (b) Schematic
representation of Aib foldamer helices interacting with a bilayer to
form a pore with activity determined by foldamer length (a, black
arrows) and foldamer−foldamer interactions (b, white arrows).
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compare well to anticipated lengths for these compounds,
calculated as 2.24 and 3.01 nm, respectively, using 0.194 nm per
Aib in a 310 helix, with 0.24 nm added for the azido group and
0.64 nm added for the OCH2CH2SiMe3 group. All compounds
were found to pack in oﬀset head-to-tail arrangements (see
Supporting Information).25,28 The unit cell also revealed side-
to-side packing of the helices, a geometry important for the
formation of membrane-spanning pores/channels. Heptamer 3
contained head-to-tail intermolecular hydrogen bonds between
foldamers involving the NH of the ﬁrst N-terminal Aib and
carbonyl of the penultimate amide link at the C-terminus
(NH···O distance 3.038 Å, Figure 2d) and the NH of the
second N-terminal Aib and the ﬁnal amide link at the C-
terminus (NH···O distance 2.941 Å, Figure 2e). Octamer 4
only showed intermolecular hydrogen bonding to acetonitrile
of crystallization (Figure 2b, NH···N distance 3.067 Å), and
unlike 3 and 7 both the azido group and CH2CH2TMS tail
folded back onto the helix. Undecamer 7 showed intermo-
lecular hydrogen bonds analogous to those observed for 3,
involving the ﬁrst and second N-terminal Aib residues and the
C-terminus of a neighboring foldamer (i.e., NH···O distances
2.999 and 3.130 Å, respectively).
Foldamer Self-Association. The self-association of Aib
oligomers in CDCl3 may be quantiﬁed by ﬁtting the
concentration dependence of NH chemical shifts to either
dimerization or isodesmic self-association (with equal K values)
models.29 Such self-association in nonpolar environments is a
key aspect of most proposed mechanisms of action of
peptaibols. However, we and others have found that aggregates
larger than dimers do not form to a signiﬁcant extent for similar
Aib oligomers in the millimolar concentration range in
chloroform.30 After ﬁtting data to a dimerization model, we
have found that longer Aib foldamers self-associate more
strongly in nonpolar solvents, as well as displaying lower
solubility.25
As found during this previous work, compounds 1−9 showed
concentration-dependent NH chemical shifts in CDCl3 but not
in CD3OD or other hydrogen bond donor/acceptor solvents.
25
These shifts in CDCl3, a solvent that replicates the low polarity
at the center of the bilayer,31 allowed the dimerization constant
K of 1, 2, 4, 7−9 to be quantiﬁed by 1H NMR spectroscopy
(Table 1, corresponding dissociation constants, Kd, and curve
ﬁtting errors also shown). The NH resonances of these
foldamers were monitored as the solutions were diluted, with
marked changes in chemical shift observed for some NHs in the
longer foldamers even at relatively low concentrations. For
Scheme 1. Synthesis of Foldamers 1−9a
a(i) N3AibCl, Et3N, CH2Cl2, RT (room temperature). (ii) Pd/C,
MeOH or EtOH, H2, RT. (iii) TFA (triﬂuoroacetic acid), CH2Cl2, RT.
(iv) Ac2O, 120 °C or EDC·HCl (EDC = 1-ethyl-3-(3-
(dimethylamino)propyl)carbodiimide), CH2Cl2, RT then HAibmOR
(R = t-Bu or (CH2)2TMS; TMS = trimethylsilyl), CH3CN, 80 °C. (v)
NaN3, DMF, RT. (vi) 2-(Trimethylsilyl)ethanol, EDC·HCl, DMAP
(4-(dimethylamino)pyridine), CH2Cl2, RT. (vii) HCl in Et2O.
Figure 2. X-ray crystal structures of (a) N3Aib7OCH2CH2TMS 3, (b)
N 3 A i b 8 OCH 2 CH 2 TM S 4 w i t h CH 3CN , a n d ( c )
N3Aib11OCH2CH2TMS 7. Foldamer−foldamer interactions of
N3Aib7OCH2CH2TMS 3 in the solid state, involving hydrogen
bonds from (d) the ﬁrst and (e) the second N-terminal Aib residue
to the C-terminus of a neighboring foldamer. Selected hydrogen bonds
are shown in green; black arrows indicate the continuation of the
foldamer chains.
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example, a 0.4 ppm shift for the N-terminal NH of Aib11 7 was
measured upon dilution from 40 to 1 mM, compared to a 0.05
ppm shift for the N-terminal NH proton of Aib5 1 over the
same concentration range. From these data the dimerization
constant for each compound was calculated by standard
iterative curve ﬁtting using diﬀerent minimization algorithms
(see the Supporting Information).25
The dimerization constants were <3 M−1 for the shorter
foldamers 1, 2, and 4, but 14−17 M−1 for the longer foldamers
7−9. These values, equivalent to ΔG = −7 kJ mol−1 for
dimerization of Aib13 9,
32 are consistent with previous ﬁndings
that Aib foldamers dimerize more strongly in chloroform as
oligomer length increases.25,30 Although these dimerization
constants are low, partitioning into the membrane can lead to
very large eﬀective concentrations, as the volume of the
membrane is much less than the total volume of the sample.33
For instance, 1 mol % foldamer in the membrane is equivalent
to ∼8 mM foldamer within the volume occupied by the bilayer.
At these “in membrane” concentrations, an increase in
dimerization constant from 3 to 17 M−1 (foldamers Aib8 4
and Aib13 9, respectively) would give an approximately
proportionate increase in dimerization, with a simple model
giving 4.4% of Aib8 4 present as dimer at 1 mol % foldamer
incorporation, whereas 18.2% of Aib13 9 is present as the dimer
at the same membrane loading (see the Supporting
Information).
8-Hydroxypyrenetrisulfonate (HPTS) Assays of Iono-
phoric Activity. Foldamers 1−9 were assessed for either Na+/
H+ antiport or Na+/OH− symport by means of standard HPTS
assays,34 using 1:4 cholesterol:egg yolk phosphatidylcholine
(EYPC) vesicles with an interior pH of 7.4 and an exterior pH
of 8.4.35 Aliquots of foldamers Aib5 1 to Aib13 9 in methanol
were equilibrated with suspensions of large unilamellar vesicles
(LUVs) for 180 s, before the addition of the base pulse. The
change in HPTS ﬂuorescence was measured for 27 min,
followed by addition of Triton X-100 to lyse the vesicles and
obtain the maximum change in HPTS ﬂuorescence for data
normalization (Figure 3 a).
These HPTS ﬂuorescence assays showed an initial “burst” of
activity (the “burst phase”), due to rapid ion transport through
pores/channels that formed in the vesicles before the addition
of the base pulse,36 followed by slower pH discharge over the
next 1620 s. Foldamers 1−9 could all discharge the
transmembrane pH gradient, albeit with strong concentration
dependence (data for 1, 4, and 7 shown in Figure 3 b). For the
shorter Aibm foldamers (m = 5, 6, 7, 8), a high concentration of
10 μM was required for activity, whereas for the longer Aib m-
mers (m = 9, 10, 11, 12, 13) a 0.6 μM concentration was
suﬃcient to show high activity. As these data suggest, the
ionophoric activity of these oligomers was markedly length-
dependent, with longer molecules signiﬁcantly more active. For
example, 0.08 mol % of undecamer 7 (0.6 μM of Aib11) was
able to discharge 70% of the pH gradient within 10 min, but
0.08 mol % heptamer 3 (0.6 μM of Aib7) only discharged 7%
over the same time period (Figure 3 a). Shorter oligomers such
as pentamer Aib5 1 only discharged most of the pH gradient at
concentrations >200 μM (>26 mol %, see the Supporting
Information).
The slower change in ﬂuorescence after the “burst phase”
encompasses several molecular level events, including the rate
of intervesicle transfer of foldamers.36 Nonetheless, to gauge
the relative eﬀectiveness of the compounds as ionophores, all
the data was ﬁtted to ﬁrst-order reaction kinetics as an
approximation; this provided consistent observed rate constant
values within an error of 5%. Control experiments using
methanol only were subtracted from the experimental data to
correct for leakage caused by the solvent.
These observed rate constants (kobs, Figure 4) conﬁrmed that
the longer oligomers, such as Aib11 7 (kobs = (3.3 ± 0.4) × 10
−3
s−1), show very powerful activity. Under the same conditions
(0.6 μM peptide in EYPC/cholesterol), an HPTS assay showed
the natural Aib-containing peptaibol alamethicin had kobs = (2.7
± 0.2) × 10−3 s−1, similar to that of foldamer Aib9, 5 (kobs =
(2.4 ± 0.3) × 10−3 s−1), and smaller than that of dodecamer
Aib12 8 (kobs = (5.0 ± 0.2) × 10
−3 s−1). With a reported37
hydrophobic width of EYPC/cholesterol bilayers in the region
Table 1. Experimental NMR Dimerization Constants K
(Dissociation Constants, Kd) for Foldamers 1, 2, 4, 7−9 in
CDCl3 at 298 K
oligomer K/M−1 (Kd/mM)
Aib5 1 <1 (>1000)
Aib6 2 1.2 ± 0.2 (830 ± 140)
Aib8 4 3.0 ± 1.3 (330 ± 140)
Aib11 7 17.3 ± 3.1 (58 ± 10)
Aib12 8 13.6 ± 0.6 (74 ± 3)
Aib13 9 16.9 ± 0.4 (59 ± 1)
Figure 3. (a) HPTS ﬂuorescence changes for foldamers 7 (Aib11,
blue), 5 (Aib9, green), 4 (Aib8, gray), and 3 (Aib7, red) and methanol
blank (black). Additions of foldamer solution in methanol (20 μL, 60
μM) to LUVs (20% cholesterol/EYPC, 0.76 mM lipid, 2 mL). Base
pulse of NaOH (13 μL, 1 M) at 180 s (dashed line). Data normalized
to maximum ﬂuorescence after addition of Triton X-100 [10% v/v in
MOPS buﬀer (MOPS = 3-(N-morpholino)propanesulfonic acid)] at
1800 s. (b) Plot of [foldamer] (log scale) vs pseudo-ﬁrst-order rate
constants of ion leakage from LUVs for foldamers 7 (Aib11, blue), 4
(Aib8, gray), and 1 (Aib5, brown). Curve ﬁts to guide the eye.
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of 2.8 nm, the length mismatch between the foldamer and
bilayer decreases from 1 to 9 (1.8 to 3.4 nm), with the 310-
helical decamer Aib10 6 closest in length to the hydrophobic
length estimated for α-helical 19-residue alamethicin (ca. 2.8
nm).13,14
The activities of the shorter foldamers 1−3 could not be
distinguished from the background level at the lower 0.6 μM
concentration, but their activities could be diﬀerentiated at 10
μM. The octamer Aib8 4 was then analyzed at both 10 and 0.6
μM to bridge between the two data sets. Setting the activity of
the octamer as 1.0 allowed the activity of all the other Aibm
foldamers to be approximately ranked (Figure 4).38 The relative
activities were calculated to be 0.04 (m = 5, 10 μM), 0.16 (m =
6, 10 μM), 0.28 (m = 7, 10 μM), 1.0 (m = 8), 9 (m = 9), 14 (m
= 10), 11 (m = 11), 17 (m = 12), 8 (m = 13), revealing an
approximately 400-fold diﬀerence in relative activity between
the most and least active foldamers. The sharpest increase in
activity (9-fold) occurs for the change from octamer to
nonamer. This suggests that the length of Aib9 5 (estimated as
2.62 nm, calculated as described earlier) represents the
minimum length able to span the hydrophobic core of the
bilayer (ca. 2.8 nm for EYPC, see the Supporting Information
for a representation of 310-helical Aib11 7 in an idealized
bilayer).39 Beyond foldamer Aib10 6, there appears to be a
leveling oﬀ or even a diminution of activity with further
increases in length. Interestingly it is clear that there is no
sudden appearance of ionophoric activity when these
incremental changes in foldamer length produce compounds
long enough to span the bilayer. The activity of the shorter
foldamers and the absence of a step-change in ionophoric
activity at a certain length of foldamer suggest the mechanism
for foldamer activity may be more nuanced than simply the
formation of the “barrel-stave” ion channels suggested to
explain the activity of alamethicin.11,12
The HPTS assay cannot easily discriminate between ion
channel/pore,11,12 membrane disruption,40 and ion carrier
mechanisms,41 all of which have been suggested to occur for
the structurally related peptaibols. An ion carrier mechanism for
Na+ transport by this family of foldamers was discounted as no
activity was observed over 20 h for 1, 7, and 8 in simple U-tube
assays (see the Supporting Information). To test for membrane
disruption, the dye 5/6-carboxyﬂuorescein (5/6-CF) was
encapsulated within vesicles at self-quenching concentrations.
If an added compound disrupts the bilayer and/or forms pores
greater than the size of 5/6-CF (ca. 10 Å for 5/6-CF42
compared to ca. 2 Å for sodium43), the dye will escape from the
vesicle lumen and give a recovery in emission at 517 nm (λex
492 nm). As with the HPTS assay, the addition of Triton X-100
releases all entrapped 5/6-CF and allows normalization of the
data. When Aib foldamers Aib7 3, Aib11 7, and Aib13 9 were
tested for 5/6-CF release from EYPC/cholesterol vesicles, it
was clear that very little dye release occurred; foldamers 3, 7,
and 9 caused only 3%, 3%, and 5% leakage of 5/6-CF over 1200
s at concentrations of 10, 0.6, and 0.6 μM, respectively. The
same compounds gave ionophoric activities of 60−75% at the
same concentrations under analogous conditions (Figure 5).
This observation shows that membrane disruption by these
compounds is not signiﬁcant under these conditions and
suggests the majority of ion channels or pores formed by 3, 7,
and 9 at these membrane loadings are not large enough to
allow 5/6-CF release.44
Planar Bilayer Conductance (PBC) Assays of Iono-
phoric Activity. PBC measurements allow ionophoric activity
due to pores and/or channels to be identiﬁed and the stability
of these conducting structures to be assessed, although the
mechanism of ion conductance in HPTS vesicle experiments is
not necessarily the same under the applied potential used in
PBC measurements.45 After application of a potential across the
bilayer, if channels or pores form then sudden and intermittent
increases in current occur, the length of which correlate to the
kinetic stability of an “open” channel.46 Such voltage-clamp
techniques can be used to observe single channel activities,
Figure 4. Plot of apparent ﬁrst-order rate constants for Na+ transport
vs number of Aib residues for foldamers (a) Aib5 1 to Aib8 4 at 10 μM,
and (b) Aib8 4 to Aib13 9 at 0.6 μM. Additions of foldamer stock
solution in methanol (20 μL) to 0.76 mM LUVs (20% cholesterol/
EYPC, 2 mL). (c) Estimation of relative rate constants with foldamer
length, at 10 μM (1−4) and 0.6 μM (4−9), normalized to relative rate
of Aib8 4 at both concentrations (krel = 1).
Figure 5. Co-plot of normalized HPTS ion transport data (●) and 5/
6-CF release data () for 3 (Aib7, 10 μM, red), 7 (Aib11, 0.6 μM,
blue), and 9 (Aib13, 0.6 μM purple). Additions of foldamer solution in
methanol to LUVs (20% cholesterol/EYPC, 0.76 mM lipid, 2 mL) at 0
s (HPTS data, base pulse at 180 s) or 180 s (5/6-CF data).
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multiple conductance states for self-assembled channels, and
ensemble conductance from multiple channels.47
Selected foldamers 3, 4, 7, 9 (N3AibmOCH2CH2TMS, m = 7,
8, 11, 13) were assessed for their ability to conduct ions
through planar phospholipid bilayer membranes composed of
1:4 cholesterol:EYPC. The shorter foldamers Aib7 3 and Aib8 4
at concentrations of 2.5 or 5 μM generally produced irregular
and spiky conductances in the current−voltage sweeps (I−V
sweeps from +100 mV to −100 mV), which indicates transient
membrane disruption by the peptides. At higher concentrations
the bilayers became unstable; e.g., 10 μM Aib8 4 gave multilevel
activity after ∼0.5 h at high positive or high negative applied
potential, but the shape of the I−V curves suggests progressive
membrane weakening until eventually the membranes broke
(see Supporting Information). In contrast, current−voltage
sweeps from −100 to +100 mV for compounds Aib11 7 and
Aib13 9 at 0.6 μM displayed a range of ensemble conductances.
The ﬂux that passed was seen to gradually increase until a
maximum conductance was reached after ca. 2.5 h, after which
time the conductance reached an equilibrium value between 50
and 80 pA/0.5−0.8 nS at an applied voltage of 100 mV (see
Supporting Information).
At a set voltage, both 7 and 9 gave intermittent increases in
current over time (Figure 6a−c). Both compounds exhibited
multiple conductance states and maintained this reproducible
behavior for at least 16 h, after which time the bilayer was still
intact. Only a few seconds were required for this channel/pore
behavior to start appearing, indicating fast diﬀusion into and
across the bilayer. Classical “square-top” traces were not
observed, with the traces instead showing ﬂickering con-
ductance events, with poorly deﬁned current levels and short
transition lifetimes. Integer steps in the conductance levels were
not observed, suggesting that multiple openings of the same
type of pore do not occur. Instead, the diﬀerent conductance
states, which range from 1.3 to 1.5 nS (Figure 6a−c), may
result from pores with diﬀering molecularities and correspond-
ingly diﬀerent conductances, similar in behavior to the
amphiphilic heptapeptides reported by Ferdani and Gokel.48
This voltage-dependent formation of short-lived, multilevel
pores/ion channels is also characteristic for some neutral and
many cationic toroidal or α-barrel-forming peptides like
melittin and oligo(Ala-Aib-Ala-Aib-Ala).49 Synthetic ion
channels typically give conductances between 1 and 100 pS,
whereas pores give conductances between 0.1 and 5 nS,50
suggesting that foldamers 7 and 9 form pore-like structures.
Very low foldamer concentrations (5−50 nM) were assessed
for channel formation using droplet−interface bilayers (DIBs,
see the Supporting Information).51 However, DIB studies on 2
(6-mer) and 7 (11-mer) did not indicate that defects of a
predeﬁned radius were formed, but at these very low
concentrations the foldamers induced points of weakness that
nucleated electropores.52
The current−voltage sweeps for Aib11 7 and Aib13 9 at 0.6
μM showed a nonlinear relationship between current and
voltage, with higher conductance at high voltages (Figure 6 d),
nonohmic behavior similar to that found for other antimicrobial
peptides including alamethicin.12b,15 The increase in con-
ductance at high voltages could be due to a reduction in the
energy barrier to pore formation,52 or the interaction of the
stronger applied ﬁeld with the foldamer dipole causing more
transmembrane geometries.53 The I−V curves also show
asymmetric conductance behavior (see the Supporting
Information), behavior that is diﬀerent from that observed for
symmetric pores based on β-sheets (where the opposing
backbone orientations produce no net macrodipole) and
dipole-free octiphenyl rigid-rod channels.49,54 This behavior
suggests a lack of symmetry when interacting with the
membrane. Peptide foldamers, such as Aib11 7 and Aib13 9,
have diﬀerent termini and intrinsic end-to-end asymmetry that
produces a signiﬁcant dipole moment.55 Since these com-
pounds are added solely to the cis side of the PBC bilayer,
easier insertion of the small azido group into the bilayer over
the bulky TMS group would produce an asymmetric foldamer
alignment in the bilayer, which may either match or oppose the
changing applied voltage.56
■ CONCLUSIONS
Simple and versatile synthetic methodology has given access to
a homologous family of functionalizable 310-helical Aib
foldamers containing from 5 to 13 Aib residues. All members
were active as ionophores, but only foldamers that are able to
form 310 helices longer than the thickness of the hydrophobic
core of the bilayer gave high conductance pores. Aib foldamers
that were too short to span the membrane were much less
active. They may act through an “amyloid-like” mechanism that
has been suggested for other short Aib foldamers,57 where at
high concentrations the foldamers assemble in or around the
membrane surface, porating and weakening the bilayer. The
longer foldamers were remarkably eﬀective ionophores. In the
Figure 6. Typical planar bilayer conductance behavior for 7 and 9. (a)
7 (Aib11, 0.6 μM), applied voltage −100 mV, current passed −150 pA;
1.5 nS. (b) 9 (Aib13, 0.6 μM), applied voltage +100 mV, current passed
+145 pA, with smaller conducting state also observed at +130 pA; 1.45
or 1.3 nS, respectively. (c) 9 (Aib13), 0.6 μM concentration, applied
voltage +100 mV, current passed +145 pA; 1.45 pS. (d) Example I−V
traces: 9 (Aib13, purple) and 7 (Aib11, blue), traces approximately 1 h
after addition of compound.
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HPTS assay the observed rate constant for transport by
dodecamer Aib12 8 was twice that of the naturally occurring 19-
residue antibiotic alamethicin.
Many natural and artiﬁcial channel/pore formers are believed
to achieve activity by self-associating in the membrane, with
“barrel-stave”, “carpet”, and “toroidal-pore”6 mechanisms
invoking the formation of deﬁned or ill-deﬁned aggregates.
We found that increasing the length of Aib foldamers increased
the strength of self-association in nonpolar environments, a
principle that may extend to other peptides or foldamers in
bilayers. However, the increase in ionophoric activity with
length was stronger than the increase in self-association with
length; for example, Aib11 7 was 91 times more membrane-
active than Aib6 2 and 12 times more active than Aib8 4,
whereas K for Aib11 7 was only 14 times greater than K for Aib6
2 and 5.8 times greater than K for Aib8 4. These data suggest a
key factor for good ionophoric activity is the ability to achieve a
membrane-spanning conformation. Ionophoric activity was
similar for foldamers with m = 10 and 13 (lengths from ∼2.8
to ∼3.4 nm), implying that 2.8 nm is the ideal length for these
foldamers to span EYPC/cholesterol bilayers (∼2.8 nm
hydrophobic width) and further increases in foldamer length
have little inﬂuence on activity.
The potent ionophoric activity of the longer foldamers
suggests they may have rich potential in new generation
antibiotics. Much like the Aib-rich peptaibols themselves, they
should be resistant to proteases, yet the azido and
CH2CH2TMS protecting groups allow simple synthetic
modiﬁcation of the N- and/or C-termini. Simple modiﬁcations
such as adding chiral28,58 or hydrogen bonding groups to the
termini could increase activity by strengthening aggregation in
the bilayer.25 Alternatively, speciﬁc cell-targeting groups, such
as saccharides or biotin, could be added.35,59
The membrane activity reported here for conformationally
deﬁned Aib foldamers gives a hint of the wider potential of
these nanoscale building blocks. These studies have shown that
an Aibm (m = 10−12) core is suﬃcient achieve a membrane-
spanning geometry. Since both the N- and C-termini can be
easily modiﬁed, these helical transmembrane units could
therefore be used as scaﬀolds for the construction of functional
GPCR mimics. For example, foldamers 6−9 exist as racemic
mixtures of interconverting right- and left-handed helices, but
controlling the helical screw-sense distribution can provide a
means of relaying information along the helix.60 Given that,
noncovalent reversible switching of chiral control should lead
to end-to-end transmission of conformational change, and
ultimately information communication across a bilayer.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/jacs.5b12057.
Additional research data supporting this publication are
available from the eScholar repository at DOI: 10.15127/
1.294101.
Full experimental details including 1H and 13C NMR
spectra of new compounds, ﬁtting of HPTS data, U-tube
data, PBC data/calculations, dimerization constant data/
calculations, and DIB procedures/data (PDF)
Crystallographic data for compounds 3, 4, and 7 (CIF)
■ AUTHOR INFORMATION
Corresponding Authors
*j.clayden@bristol.ac.uk
*S.Webb@manchester.ac.uk
Author Contributions
J.E.J. and V.D. contributed equally.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
We gratefully acknowledge Dr. J. Sanderson for the “NMR
dilution ﬁt” Excel spreadsheet used for dimerization constant
determination. This work was supported by the BBSRC (Grant
I007962), ESPRC (Grants EP/N009134/1 and EP/K039547),
and the ERC (Advanced Grant ROCOCO).
■ REFERENCES
(1) Azzarito, V.; Long, K.; Murphy, N. S.; Wilson, A. J. Nat. Chem.
2013, 5, 161−173.
(2) Murphy, J. E.; Uno, T.; Hamer, J. D.; Cohen, F. E.; Dwarki, V.;
Zuckermann, R. N. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 1517−1522.
(3) (a) Bautista, A. D.; Craig, C. J.; Harker, E. A.; Schepartz, A. Curr.
Opin. Chem. Biol. 2007, 11, 685−692. (b) Hennig, A.; Gabriel, G. J.;
Tew, G. N.; Matile, S. J. Am. Chem. Soc. 2008, 130, 10338−10344.
(4) (a) Claudon, P.; Violette, A.; Lamour, K.; Decossas, M.; Fournel,
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